|
[Notice] Results of 2006 Drug Reevaluation
2007.01.19
|
|---|
|
[Notice] Results of the 2006 Drug Reevaluation
In accordance with Article 26-3 and Article 34, Paragraph 4 of the Pharmaceutical Affairs Act and the [Regulations on the Implementation of Drug Reevaluation (KFDA Notification)], a reevaluation was conducted for 636 products across 13 therapeutic classes for blood and body fluids. The results are hereby announced.
*** See relevant products below ***
Silotal Tab (Cilostazol) [link] Tramin Injection 250 mg (Tranexamic Acid) Tramin Injection 500 mg Herin Injection (Heparin Sodium)
For inquiries regarding this notice: Responsible Department: Daehan New Pharm R&D Division Contact: 02-3415-7857 |


Home